83915-83-7
83915-83-7
Chemical Structure
Lisinopril dihydrate
Synonym(s): MK-521 dihydrate
- CAS No.: 83915-83-7
- Formula:C21H35N3O7
- Molecular Weight:441.52
IUPAC Name: ((S)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline dihydrate
InChIKey: CZRQXSDBMCMPNJ-ZUIPZQNBSA-N
SMILES: O=C(O)[C@H]1N(C([C@H](CCCCN)N[C@H](C(O)=O)CCC2=CC=CC=C2)=O)CCC1.O.O
Biological Activity: Lisinopri dihydrate (MK-521 dihydrate) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lisinopril dihydrate | 99.96% | Lisinopri dihydrate (MK-521 dihydrate) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lisinopril dihydrate (Standard) | ≥98% | Lisinopril (dihydrate) (Standard) is the analytical standard of Lisinopril (dihydrate). This product is intended for research and analytical applications. Lisinopri dihydrate (MK-521 dihydrate) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
